{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:55:30Z","timestamp":1768730130957,"version":"3.49.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/gco.0b013e32834b92b0","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T23:52:35Z","timestamp":1317772355000},"page":"427-434","source":"Crossref","is-referenced-by-count":38,"title":["Ovarian aging"],"prefix":"10.1097","volume":"23","author":[{"given":"Johnny S.","family":"Younis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","article-title":"Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.","volume":"7","author":"Faddy","year":"1992","journal-title":"Hum Reprod"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(99)00238-5","article-title":"Follicle dynamics during ovarian ageing.","volume":"163","author":"Faddy","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/humrep\/dem408","article-title":"A new model of reproductive aging: the decline in ovarian nongrowing follicle number from birth to menopause.","volume":"23","author":"Hansen","year":"2008","journal-title":"Hum Reprod"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.fertnstert.2009.12.045","article-title":"Antral follicle count: absence of significant midlife decline.","volume":"94","author":"Rosen","year":"2010","journal-title":"Fertil Steril"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients.","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil Steril"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive ageing.","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/humrep\/deg245","article-title":"Early ovarian ageing: a hypothesis. Detection and clinical relevance.","volume":"18","author":"Nikolaou","year":"2003","journal-title":"Hum Reprod"},{"key":"R11-6-20210129","first-page":"2395","article-title":"Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF) Hum R","volume":"24","author":"Gleicher","year":"2009","journal-title":"eprod"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/humrep\/deg278","article-title":"Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment.","volume":"18","author":"de Boer","year":"2003","journal-title":"Hum Reprod"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humrep\/deg101","article-title":"Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis.","volume":"18","author":"Lawson","year":"2003","journal-title":"Hum Reprod"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.maturitas.2009.06.007","article-title":"Testing ovarian reserve to predict age at menopause.","volume":"63","author":"Lambalk","year":"2009","journal-title":"Maturitas"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/humupd\/dmp055","article-title":"Human studies on genetics of the age at natural menopause: a systematic review.","volume":"16","author":"Voorhuis","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/JME-10-0070","article-title":"Genes involved in human premature ovarian failure.","volume":"45","author":"Persani","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tem.2007.01.004","article-title":"Female reproductive ageing: current knowledge and future trends.","volume":"18","author":"Broekmans","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0065-2660(07)00417-8","article-title":"Study designs for genome-wide association studies.","volume":"60","author":"Kraft","year":"2008","journal-title":"Adv Genet"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/humrep\/dep276","article-title":"Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.","volume":"24","author":"Soto","year":"2009","journal-title":"Hum Reprod"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breastovarian cancer risks.","volume":"28","author":"Oktay","year":"2011","journal-title":"J Clin Oncol"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/jc.2010-2244","article-title":"Fertility and ovarian function in high-dose estrogen-treated tall women.","volume":"96","author":"Hendriks","year":"2011","journal-title":"J Clin Endocrin Metab"},{"key":"R22-6-20210129","first-page":"248","article-title":"Aging and infertility in women.","volume":"86S","year":"2006","journal-title":"Fertil Steril"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome.","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R24-6-20210129","first-page":"2264","article-title":"","volume":"24","author":"La Marca","year":"2009","journal-title":"on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round TableAnti-Mullerian hormone (AMH): what do we still need to know Hum Reprod"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.fertnstert.2010.07.1042","article-title":"Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.","volume":"95","author":"Riggs","year":"2011","journal-title":"Fertil Steril"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.fertnstert.2011.02.057","article-title":"Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study.","volume":"95","author":"Almog","year":"2011","journal-title":"Fertil Steril"},{"key":"R28-6-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/GCO.0b013e3283384911","article-title":"The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome.","volume":"22","author":"Broer","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1472-6483(10)60019-3","article-title":"Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy.","volume":"18","author":"Maheshwari","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.fertnstert.2006.11.006","article-title":"Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count.","volume":"87","author":"Hendriks","year":"2007","journal-title":"Fertil Steril"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization.","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil Steril"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2010.07.1069","article-title":"Age-specific nomogram for the decline in antral follicle count throughout the reproductive period.","volume":"95","author":"La Marca","year":"2011","journal-title":"Fertil Steril"},{"key":"R33-6-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.fertnstert.2010.08.047","article-title":"Age-related normogram for antral follicle count: McGill reference guide.","volume":"95","author":"Almog","year":"2011","journal-title":"Fertil Steril"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/09513590701331267","article-title":"Undetectable basal ovarian stromal blood flow in infertile women is related to low ovarian reserve.","volume":"23","author":"Younis","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R35-6-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.fertnstert.2005.07.1300","article-title":"A model for predicting age at menopause in white women.","volume":"85","author":"Hefler","year":"2006","journal-title":"Fertil Steril"},{"key":"R36-6-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00439-010-0878-4","article-title":"A large-scale candidate gene association study of age at menarche and age at natural menopause.","volume":"128","author":"He","year":"2010","journal-title":"Hum Genet"},{"key":"R38-6-20210129","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/deh216","article-title":"Assessment of ovarian reserve. Ovarian biopsy is not a valid method for the prediction of ovarian reserve.","volume":"19","author":"Lambalk","year":"2004","journal-title":"Hum Reprod"},{"key":"R39-6-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.","volume":"25","author":"Van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"R40-6-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis.","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R41-6-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humupd\/dmn001","article-title":"The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis.","volume":"14","author":"Verhagen","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R42-6-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.fertnstert.2009.03.036","article-title":"A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women.","volume":"94","author":"Younis","year":"2010","journal-title":"Fertil Steril"},{"key":"R43-6-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction.","volume":"22","author":"La Marca","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"R44-6-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/humupd\/dmm043","article-title":"Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age.","volume":"14","author":"Jones","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R46-6-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-7-101","article-title":"Biological versus chronological ovarian age: implications for assisted reproductive technology.","volume":"7","author":"Alviggi","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"R47-6-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","article-title":"How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.","volume":"91","author":"Kyrou","year":"2009","journal-title":"Fertil Steril"},{"key":"R49-6-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.rbmo.2009.10.017","article-title":"Modified natural cycle IVF and mild IVF: a 10 year Swedish experience.","volume":"20","author":"Aanesen","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R50-6-20210129","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy.","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-6-20210129","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1472-6483(10)61165-0","article-title":"Impact of androgen on fertility: physiological, clinical and therapeutical aspects.","volume":"11","author":"Hugues","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"R52-6-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/den428","article-title":"Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.","volume":"24","author":"Fabregues","year":"2009","journal-title":"Hum Reprod"},{"key":"R53-6-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"R54-6-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertile Steril"},{"key":"R55-6-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10815-007-9178-x","article-title":"Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.","volume":"24","author":"Barad","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"R56-6-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1477-7827-7-108","article-title":"Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.","volume":"7","author":"Gleicher","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"R57-6-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1477-7827-8-140","article-title":"Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS).","volume":"8","author":"Gleicher","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"R58-6-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rbmo.2010.04.006","article-title":"Improvement in diminished ovarian reserve after dehydroepiandrosterone (DHEA) supplementation.","volume":"21","author":"Gleicher","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R59-6-20210129","first-page":"1941","article-title":"DHEA as a miracle drug in the treatment of poor responders; hype or hope Hum R","volume":"26","author":"Yakin","year":"2011","journal-title":"eprod"},{"key":"R60-6-20210129","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study.","volume":"25","author":"Wiser","year":"2010","journal-title":"Hum Reprod"},{"key":"R61-6-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.2010.05934.x","article-title":"Oocyte donation programs: strategy for improving results.","volume":"1221","author":"Borini","year":"2011","journal-title":"Ann NY Acad Sci"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e32834b92b0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:17:38Z","timestamp":1620951458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201112000-00006"}},"subtitle":["latest thoughts on assessment and management"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e32834b92b0","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}